D Narsimhaswamy1, Kurra Mohan2 and Ravi Varala3*
112001, Belcher Rd S; Apt No: N226, Largo Florida, USA
2Department of Pharmaceutical Chemistry, Telangana University, Nizamabad, Telangana, India
3Scrips Pharma, Mallapur, Hyderabad, Telangana, India
*Corresponding Author: Ravi Varala, Scrips Pharma, Mallapur, Hyderabad, Telangana, India.
Received: November 30, 2021; Published: December 20, 2021
This commentary briefly discusses the necessity of utilizing repurposed drugs/vaccines to combat against evil covid-19. As new variants are (such as Omicron) emerging out due to undergoing mutations by virus, urge of developing more efficient drugs is necessary both in terms of efficacy and safety.
Keywords: n-Covid; Vaccines; Efficacy; Safety; Mutations; Variants; Drugs; Repurpose
Citation: Ravi Varala., et al. “n-Covid Drugs and their Relevance in Present Day Scenario". Acta Scientific Pharmaceutical Sciences 6.1 (2022): 113-115.
Copyright: © 2022 Ravi Varala., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.